BrainCheck Announces Grant Program for Brain and Cognitive Disorders Research

August 3, 2022 / Nueterra Capital Marketing

BrainCheck | A Nueterra Capital Portfolio Company

BrainCheck, a Nueterra Capital portfolio company providing interactive cognitive assessment and cognitive care planning technology, has announced a new research grant program. The Investigator Initiated Research (IIR) Grant Program will help fund research for evaluation, diagnosis, treatment, and care for brain-related diseases, including Alzheimer’s disease and related dementias (ADRD), postoperative delirium, stroke, traumatic brain injury, and post-acute Covid “brain fog,” according to a press release issued by BrainCheck. Grant recipients will be provided with one year of research funding and free access to BrainCheck’s platform.